Total planned funding: $3,374,082,589
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $648,530,004 |
Zambia | $551,272,808 |
Tanzania | $507,759,640 |
Mozambique | $327,497,336 |
Uganda | $253,746,944 |
Kenya | $229,395,410 |
Zimbabwe | $161,560,606 |
Rwanda | $122,907,971 |
Democratic Republic of the Congo | $108,626,117 |
Haiti | $107,412,696 |
Ethiopia | $67,611,992 |
Côte d'Ivoire | $43,239,577 |
Eswatini | $28,867,459 |
South Africa | $28,676,255 |
Vietnam | $27,636,072 |
Ukraine | $21,792,383 |
Cameroon | $21,105,945 |
Malawi | $19,136,129 |
Burundi | $16,261,392 |
Lesotho | $12,796,990 |
Namibia | $12,238,925 |
West Africa Region | $11,139,691 |
Western Hemisphere Region | $9,561,082 |
Angola | $8,750,494 |
Asia Regional Program | $5,949,606 |
South Sudan | $5,282,118 |
Botswana | $3,972,866 |
Ghana | $3,771,918 |
Indonesia | $2,200,001 |
Caribbean Region | $1,746,596 |
Central America Region | $1,487,150 |
Burma | $1,050,000 |
Cambodia | $490,000 |
enumerations.Philippines | $358,416 |
Central Asia Region | $250,000 |
Organizational Types
Private Contractor | $3,374,082,589 |
Program Areas
Treatment | $2,693,260,506 |
Care | $249,458,676 |
Prevention | $177,879,747 |
Governance and Systems | $153,867,601 |
Testing | $95,550,937 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,879,775,370 |
HTXS: Treatment: Adult Treatment | $706,295,554 |
OHSS: Health Systems Strengthening | $123,554,394 |
HBHC: Care: Adult Care and Support | $113,408,824 |
PDTX: Treatment: Pediatric Treatment | $107,189,582 |
HVCT: Testing: HIV Testing and Counseling | $95,550,937 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $87,172,835 |
HVTB: Care: TB/HIV | $78,317,514 |
HVOP: Sexual Prevention: Other Sexual Prevention | $45,309,996 |
PDCS: Care: Pediatric Care and Support | $35,671,229 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $35,181,692 |
HKID: Care: Orphans and Vulnerable Children | $22,061,109 |
HLAB: Laboratory Infrastructure | $21,829,634 |
HVSI: Strategic Information | $8,483,573 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,417,541 |
HMIN: Biomedical Prevention: Injection Safety | $3,389,130 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,934,530 |
HMBL: Biomedical Prevention: Blood Safety | $474,023 |
Top Partner Programs
Chemonics International:
$3,374,082,589
View countries